Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expression
- 1 April 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 343 (1) , 69-76
- https://doi.org/10.1016/j.bbrc.2006.02.080
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Saccharomyces boulardiiInterferes with EnterohemorrhagicEscherichia coli-Induced Signaling Pathways in T84 CellsInfection and Immunity, 2003
- The place of probiotics in human intestinal infectionsInternational Journal of Antimicrobial Agents, 2002
- Experimental effects of Saccharomyces boulardii on diarrheal pathogensMicrobes and Infection, 2002
- cag+ Helicobacter pylori Induce Transactivation of the Epidermal Growth Factor Receptor in AGS Gastric Epithelial CellsJournal of Biological Chemistry, 2001
- The IκB/NF-κB system: a key determinant of mucosal inflammation and protectionAmerican Journal of Physiology-Cell Physiology, 2000
- Saccharomyces boulardii in Maintenance Treatment of Crohn’s DiseaseDigestive Diseases and Sciences, 2000
- Regulation of Interleukin-8 Gene ExpressionJournal of Interferon & Cytokine Research, 1999
- Mechanisms by which IκB proteins control NF-κB activityProceedings of the National Academy of Sciences, 1999
- Biotherapeutic AgentsPublished by American Medical Association (AMA) ,1996
- Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileumGastroenterology, 1993